SCHEMBL17636643

SCHEMBL17636643

c1ccc(-c2nc(-c3ccccc3)n(-c3ccc4c5ccccc5n(-c5cccc(-n6c7ccccc7c7ccccc76)c5)c4c3)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NR1H3 Q13133 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
NR1H2 P55055 1/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 2/20 0.38
MEN1 O00255 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
ADORA3 P0DMS8 1/20 0.36
ADORA1 P30542 1/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17636642 0.93 KDM4E (0.41) KDM4EATML3MBTL1NR1H3NPC1
SCHEMBL17636666 0.93 KDM4E (0.41) KDM4EATML3MBTL1NR1H3NPC1
SCHEMBL17636645 0.91 KDM4E (0.41) KDM4EATML3MBTL1NR1H3NPC1
SCHEMBL21532497 0.90 KDM4E (0.35) KDM4EATML3MBTL1NR1H3NPC1
SCHEMBL21532760 0.88 SLC5A1 (0.33) KDM4EATML3MBTL1KMT2AGAA
SCHEMBL21532369 0.88 SLC5A1 (0.33) KDM4EATML3MBTL1KMT2AGAA
SCHEMBL17636822 0.88 PDPK1 (0.41) KDM4EATMKMT2AMEN1ALDH1A1
SCHEMBL15304456 0.88 KDM4E (0.41) KDM4EATML3MBTL1NR1H3NPC1
SCHEMBL17636650 0.87 MAPT (0.43) L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL21532249 0.86 MEN1 (0.32) KMT2AGAAMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960365-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-9960365-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-03-31 US disclosed
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, CCNA1 KDM4E 2877/4885ATM 1091/4885L3MBTL1 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.